IgA nephropathy: Challenges and opportunities

Cleveland Clinic Journal of Medicine

Volumn 75, Issue 8, 2008, Pages 569-576

  Glassock, Richard J ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN II; IMMUNOSUPPRESSIVE AGENT;

CHRONIC KIDNEY FAILURE; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PROGNOSIS; REVIEW; RISK FACTOR;

ANGIOTENSIN II; DIAGNOSIS, DIFFERENTIAL; DISEASE PROGRESSION; GLOMERULONEPHRITIS, IGA; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY FAILURE, CHRONIC; PROGNOSIS; RISK FACTORS;

EID: 51349098242     PISSN: 08911150     EISSN: None     Source Type: Journal    
DOI: 10.3949/ccjm.75.8.569     Document Type: Review

References (26)

1. Tomino Y, editor. IgA nephropathy today. Contrib Nephrol 2007; 157:1-255.
2. D'Amico G. The commonest glomerulonephritis in the world: IgA nephropathy. Quart J Med 1987; 245:709-727.
3. Lee G, Glassock RJ. Immunoglobulin A nephropathy. In: Ponticelli C, Glassock R, editors. Treatment of Primary Glomerulonephritis. Oxford: Oxford Medical Publication, 1997:187-217.
4. Donadio JV, Grande JP. IgA nephropathy. N Engl J Med 2002; 347:738-748.
5. Glassock RJ. Concluding remarks. IgA nephropathy today. Contrib Nephrol 2002; 157:169-173.
6. Berger J, Hinglais N. Les dépots intercapillaries d'IgA-IgG. J Urol Nephrol (Paris) 1968; 74:694-700.
7. Moldoveanu Z, Wyatt RJ, Lee JY, et al. Patients with IgA nephropathy have increased serum galactose deficient IgA, levels. Kidney Int 2002; 71:1148-1154.
8. Kincaid-Smith P, Fairley K. The investigation of hematuria. Semin Nephrol 2005; 25:127-135.
9. Coppo R, D'Amico G. Factors predicting progression of IgA nephropathies. J Nephrol 2005; 18:503-512.
10. Donadio JV, Bergstralh EJ, Grande JP, Rademcher DM. Proteinuria patterns and their association with subsequent end-staqe renal disease in IgA nephropathy. Nephrol Dial Transplant 2002; 17:1197-1203.
11. Cook T. Interpretation of renal biopsies in IgA nephropathy. Contrib Nephrol 2007; 157:44-49.
12. Bartosik LP, Lajole G, Sugar L, Cattran D. Predicting progression in IgA nephropathy. Am J Kidney Dis 2001; 58:551-553.
13. Rauta V, Finne P, Fagerudd J, et al. Factors associated with progression of IgA nephropathy are related to renal function - a model for estimating risk of progression in mild disease. Clin Nephrol 2002; 58:85-94.
14. Komatsu H, Fujimoto S, Sato Y, et al. "Point of no return (PNR)" in progressive IgA nephropathy: significance of blood pressure and proteinuria management up to PNR. J Nephrol 2005; 18:690-695.
15. Schena FP, Cerullo G, Torres DD, et al; European IgA Nephropathy Consortium. Searching for IgA nephropathy candidate genes: genetic studies combined with high throughput innovative investigations. Contrib Nephrol 2007; 157:80-89.
16. Haubitz M, Wittke S, Weissinger EM, et al. Urine protein patterns can serve as a diagnostic tools in patients with IgA nephropathy. Kidney Int 2005; 67:2313-2320.
17. Barratt J, Feehally J, Smith AC. The pathogenesis of IgA nephropathy. Semin Nephrol 2004; 24:197-217.
18. Nishitani Y, Iwano M, Yamaguchi Y, et al. Fibroblast-specific protein 1 is a specific prognostic marker for renal survival in patients with IgAN. Kidney Int 2005; 68:1078-1085.
19. Barratt J, Feehally J. Treatment of IgA nephropathy. Kidney Int 2006; 69:1934-1938.
20. Pozzi C, Andrulli S, Del Vecchio L, et al. Corticosteroid effectiveness in IgA nephropathy: long-term follow-up of a randomized, controlled trial. J Am Soc Nephrol 2004; 15:157-163.
21. Ballardie FW, Roberts IS. Controlled prospective trial of prednisolone and cytotoxics in progressive IgA nephropathy. J Am Soc Nephrol 2002; 13:142-148.
22. Donadio JV, Grande JP. The role of fish oil/omega-3 fatty acid in the treatment of IgA nephropathy. Semin Nephrol 2004; 24:225-243.
23. Maes BD, Oyen R, Claes K, et al. Mycophenolate mofetil in IgA nephropathy: results of a 3-year prospective placebo-controlled randomized study. Kidney Int 2004; 65:1842-1849.
24. Goumenous DS, Davlouros P, El Nahas AM, et al. Prednis-olone and azathioprine in IgA nephropathy - a ten year follow-up study. Nephron Clin Pract 2003; 93:c58-c68.
25. Soler MG, Mir M, Rodriguez E, et al. Recurrence of IgA nephropathy and Henoch-Schönle in purpura after kidney transplantation: risk factors and graft survival. Transplant Proc 2005; 37:3705-3709.
26. Floege J. Recurrent IgA nephropathy after renal transplantation. Semin Nephrol 2004; 24:287-291.